Upasna Sharma
Martin Shkreli is an American former hedge fund manager. He is the co-founder of the hedge fund Elea Capital, MSMB Capital Management and MSMB Healthcare and former chief executive officer of the pharmaceutical firms Retrophin and Turing Pharmaceuticals. In 2016 he founded software company Godel Systems.
Biography & Early Life
Martin Shkreli was step into world on March 17, 1983 in Coney Island Hospital in the New York City to Albanian and Croatian immigrant parents. His parents were janitors when they emigrated to the United States. He, his two sisters, and his brother grew up in Sheepshead Bay, Brooklyn, in a working-class neighbourhood. Shkreli went to Hunter College. Shkreli graduated from Hunter or was expelled before his final year and completed his high school graduation at City-As-School High School, according to different sources. He did hi graduation in business administration from Baruch College in 2004.
Career
He has spent the last four years at the Cramer Berkowitz hedge fund. He worked as a financial analyst for Intrepid Capital Management and UBS Wealth Management after leaving Cramer Berkowitz. He opted to launch his own hedge fund, Elea Capital Management, throughout his career. However, following the Lehman Brothers trial, it quickly failed.
He and his childhood friend Marek Biestek created another hedge fund, MSMB, in 2009. Both Shkreli and Biestek shortlisted biotech stocks and blasted them on social media, stressing their flaws that caused their stock to plummet. Shkreli launched Retrophin, a pharmaceutical company that specialises in treating uncommon diseases. During the same year, he continued to sell Orexigen Therapeutics stock, which was a disastrous move. This leads to MSMB’s death, with around 60,000 USD in assets remaining in the company’s name.
Retrophin directors captured his lighthearted participation in 2013. He decided to stand down as CEO in September 2014 after a thorough audit. Shkreli has no concept of the year 2015. Turing Pharmaceutical was the name of his new pharmaceutical company. Ketamine (for depression), oxytocin (for birth control), and Vecamyl are the three medications produced by the business (for hypertension). He eventually purchased the Daraprim market’s rights (used to treat AIDS patients). He had increased the pill dose by an unreasonable proportion, resulting in bias. He also purchased KaloBios pharmaceuticals for Benznidazole in the same year.
In 2016, Shkreli founded Gödel Systems, a technological software startup. He was found guilty of two charges of security fraud and one count of committing fraud during a trial on August 4th, 2017. He was condemned to life in jail, but after questioning Hillary Clinton’s Facebook account, he was released on bail.
Personal Life
Martin Shkreli was in relationhip with Christie Smythe , a former reporter for Bloomberg News. But in October, 2021 Smythe announced that they had broken up their relation but remained as friends.
In May 2014, Shkreli, an enthusiastic League of Legends player, expressed interest in acquiring an eSports team.
After a single copy of the Wu-Tang Clan album Once Upon a Time in Shaolin was sold for US$2 million via Paddle8 on November 24, 2015, Shkreli won an auction for the album.
On eBay, Shkreli tried to sell Once Upon a Time in Shaolin, with the winning price exceeding $1 million. Before the sale could be consummated, he was arrested on unrelated fraud charges.
Following Shkreli’s fraud conviction in March 2018, a federal court seized $7.36 million in assets, including Once Upon a Time in Shaolin.
Age, Height, Weight
As per today’s date 19 May 2022, he is 39 years old young handsome man. His height is 5 ft 7 inches tall and weight is around 65 kg. His eyes and hair
Net Worth of Martin Shkreli in 2022
As of 2022, Shkreli’s net worth is estimated to be $70 million. Turin Pharmaceuticals, which he owns, provides the majority of his wealth. At one point, his stake in the company was worth $50 million.
